Improving initial management of lower urinary tract symptoms in primary care: costs and patient outcomes.
until further notice
SourceScandinavian Journal of Urology and Nephrology, 40, 4, (2006), pp. 300-6
Article / Letter to editor
Display more detailsDisplay less details
Centre for Quality of Care Research
Scandinavian Journal of Urology and Nephrology
SubjectEBP 3: Effective Primary Care and Public Health; EBP 4: Quality of Care; N4i 1: Pathogenesis and modulation of inflammation; NCEBP 12: Human Reproduction; NCEBP 3: Implementation Science; NCEBP 4: Quality of hospital and integrated care; NCEBP 7: Effective primary care and public health; NCEBP 9: Mental health; ONCOL 1: Hereditary cancer and cancer-related syndromes; ONCOL 4: Quality of Care
OBJECTIVE: Guidelines for primary care management of lower urinary tract symptoms in older men recommend shared decision making regarding the choice of treatment. In this study we aimed to determine the costs and patient outcomes of an implementation strategy designed to enhance uptake of these guidelines. MATERIAL AND METHODS: The intervention comprised a distance learning programme for general practitioners, comprising evidence-based information, assessment of learning needs, a knowledge test and patient education materials. The control group only received the written guidelines. A cluster randomized trial in 187 older male patients compared costs and outcomes in the two study groups. A healthcare perspective was taken in the economic evaluation, with a 3-month time horizon. The primary health outcome was patient-reported urinary symptoms at 3 months. Costs relating to the distance learning package and the healthcare provided were considered, using undiscounted standardized prices. RESULTS: Patient-reported urinary symptoms at 3 months did not differ between the study groups: 66% and 61% with moderate symptoms and 7% and 11% with severe symptoms in the intervention and control groups, respectively. The mean total costs per patient were euro28.15 lower in the intervention group (euro93.11) compared to the control group (euro121.26), mainly because of a lower number of referrals to the urologist. A bootstrap analysis showed an incremental cost-effectiveness ratio of euro111.98 (95% CI -euro423 to +euro329). CONCLUSIONS: The distance learning programme did not change health outcomes, but it reduced costs in the first 3 months after an initial consultation compared to written guidelines. Studies with a longer follow-up period are needed.
This item appears in the following Collection(s)
- Academic publications 
- Electronic publications 
- Faculty of Medical Sciences 
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.